|
Name |
3-(N-Benzyl-N-methylamino)-1,2-propanediol
|
| Molecular Formula | C11H17NO2 | |
| IUPAC Name* |
3-[benzyl(methyl)amino]propane-1,2-diol
|
|
| SMILES |
CN(CC1=CC=CC=C1)CC(CO)O
|
|
| InChI |
InChI=1S/C11H17NO2/c1-12(8-11(14)9-13)7-10-5-3-2-4-6-10/h2-6,11,13-14H,7-9H2,1H3
|
|
| InChIKey |
HGPHYOVGIFFHJB-UHFFFAOYSA-N
|
|
| Synonyms |
60278-98-0; 3-(N-Benzyl-N-methylamino)-1,2-propanediol; 3-(Benzyl(methyl)amino)propane-1,2-diol; 3-[benzyl(methyl)amino]propane-1,2-diol; EINECS 262-144-2; 3-(N-Benzyl-N-methylamino)propane-1,2-diol; SCHEMBL721952; DTXSID30975691; AKOS017262085; 3-(Benzylmethylamino)-1,2-propanediol; BS-52056; 3-[Benzyl(methyl)amino]-1,2-propanediol #; CS-0162910; FT-0729422; E77175; 1,2-Propanediol, 3-[methyl(phenylmethyl)amino]-; 3-(N-benzyl-N-Methylamino)-1,2-propanediol, AldrichCPR
|
|
| CAS | 60278-98-0 | |
| PubChem CID | 108434 | |
| ChEMBL ID | NA |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 195.26 | ALogp: | 0.5 |
| HBD: | 2 | HBA: | 3 |
| Rotatable Bonds: | 5 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 43.7 | Aromatic Rings: | 1 |
| Heavy Atoms: | 14 | QED Weighted: | 0.732 |
| Caco-2 Permeability: | -4.909 | MDCK Permeability: | 0.00102705 |
| Pgp-inhibitor: | 0 | Pgp-substrate: | 0.057 |
| Human Intestinal Absorption (HIA): | 0.522 | 20% Bioavailability (F20%): | 0.124 |
| 30% Bioavailability (F30%): | 0.815 |
| Blood-Brain-Barrier Penetration (BBB): | 0.313 | Plasma Protein Binding (PPB): | 14.43% |
| Volume Distribution (VD): | 2.933 | Fu: | 79.56% |
| CYP1A2-inhibitor: | 0.108 | CYP1A2-substrate: | 0.121 |
| CYP2C19-inhibitor: | 0.031 | CYP2C19-substrate: | 0.928 |
| CYP2C9-inhibitor: | 0.005 | CYP2C9-substrate: | 0.077 |
| CYP2D6-inhibitor: | 0.117 | CYP2D6-substrate: | 0.779 |
| CYP3A4-inhibitor: | 0.004 | CYP3A4-substrate: | 0.573 |
| Clearance (CL): | 10.402 | Half-life (T1/2): | 0.77 |
| hERG Blockers: | 0.079 | Human Hepatotoxicity (H-HT): | 0.189 |
| Drug-inuced Liver Injury (DILI): | 0.038 | AMES Toxicity: | 0.177 |
| Rat Oral Acute Toxicity: | 0.287 | Maximum Recommended Daily Dose: | 0.015 |
| Skin Sensitization: | 0.328 | Carcinogencity: | 0.095 |
| Eye Corrosion: | 0.023 | Eye Irritation: | 0.067 |
| Respiratory Toxicity: | 0.798 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC001005 | ![]() |
0.628 | D0R0UJ | ![]() |
0.553 | ||
| ENC002915 | ![]() |
0.528 | D05OIS | ![]() |
0.476 | ||
| ENC000128 | ![]() |
0.477 | D05BMG | ![]() |
0.426 | ||
| ENC000014 | ![]() |
0.476 | D0T3LF | ![]() |
0.426 | ||
| ENC000173 | ![]() |
0.457 | D0S2UG | ![]() |
0.418 | ||
| ENC000217 | ![]() |
0.444 | D0J2MJ | ![]() |
0.411 | ||
| ENC000203 | ![]() |
0.442 | D0P6UB | ![]() |
0.400 | ||
| ENC001819 | ![]() |
0.440 | D0P9AC | ![]() |
0.388 | ||
| ENC004815 | ![]() |
0.418 | D0R1CR | ![]() |
0.385 | ||
| ENC000205 | ![]() |
0.409 | D0U0RZ | ![]() |
0.380 | ||